What Happens After a Lung CT Scan?

The goal of the screening is to detect lung cancer in its earliest and most treatable stages, which gives patients a better outlook. When doctors identify lung cancers on CT screening scans before patients show any symptoms, the prognosis is more favorable.
“The evidence from four large clinical trials have demonstrated that high-risk individuals screened with low-dose CT scans are associated with lower lung-cancer-specific mortality rates,” says Matthew Schabath, PhD, a senior member in the departments of cancer epidemiology and thoracic oncology at Moffitt Cancer Center in Tampa, Florida.
“It is fast, painless, and is covered by Medicare and by most healthcare plans,” Dr. Schabath says.
While the test itself is simple, what happens afterward can be more complicated. Sometimes more testing is needed. You may receive a false-positive result, where the CT reveals a nodule but further workup shows that it’s not cancerous. Or you may face the most serious result of the CT scan: a cancer diagnosis. Here’s what you need to know about the testing process.

If you're at high risk for lung cancer, it's recommended you get a computed tomography (CT) scan every year. Here's what you need to know about the test.
Everyday HealthWhat Happens During Low-Dose CT Screening for Lung Cancer?
A technician will talk to you and might instruct you to hold your breath at specific times.
The test is painless and takes only about five minutes. Most of the time, patients get their results the same day or within a few days.
Once your results are in, your doctor will discuss the findings with you.
If your lung CT scan results are normal, that means your lungs are clear, and you won’t need another screening until your next yearly exam.
Your doctor will analyze certain features of the nodule to determine if it’s more or less likely to be cancerous.
What if I Have a Low-Risk Nodule?
If a repeat scan reveals that the nodule has grown or changed, your healthcare provider might recommend that you have a positron emission tomography (PET) scan to get a better look.
In some cases, a biopsy is recommended. A biopsy involves removing a sample of tissue to examine under a microscope and possibly be used for additional testing.
What if a Nodule Looks Suspicious?
- Needle Biopsy With this procedure, a needle is inserted through the chest wall into the lung to take out a sample of tissue. Imaging technology may be used to guide the biopsy needle into the correct spot.
- Transbronchial Biopsy This is done with a bronchoscope — a long, thin tube with a camera on the end. The scope is placed down the throat through the windpipe and into the main airways of the lungs. Transbronchial biopsies might be guided by navigational or robotic technologies.
- Thoracoscopic Biopsy This method involves placing an endoscope — a flexible, lighted tube — into the chest cavity. Tools used through the scope remove small pieces of lung tissue.
- Open Biopsy A surgical incision in the skin is made to get to the lung and remove a piece of tissue. This method is typically used if the sample obtained from a needle biopsy is too small to make an accurate diagnosis.
There are risks involved with lung biopsies, which vary depending on the type of biopsy you have. Some possible complications are infection, bleeding in the lung, air or fluid buildup in the space between the lung and inner chest wall, blood clots, pneumonia, and pain.
If the results of your biopsy reveal that the tissue is cancerous, you and your physician will work together to come up with an optimal treatment plan.
False Positives: A Drawback to Lung CT?
A downside to CT screening for lung cancer is that the test can have false-positive findings that lead to unnecessary medical procedures.
For instance, your doctor might spot a nodule that looks suspicious, but after further testing, turns out not to be cancerous. Sometimes, biopsies or surgeries are performed when they aren’t needed. False positives also trigger unwarranted anxiety and stress for patients.
Coping With a Lung Cancer Diagnosis
If tests confirm you have lung cancer, there are certain measures you can take to live a better and longer life.
“Many factors have been shown to be associated with longer survival time among patients diagnosed with lung cancer,” Schabath says. “Maintaining or adopting a healthy lifestyle has been shown to benefit patients, including healthy diets, physical activity and exercise, maintaining your weight — excessive weight loss is detrimental for lung cancer patients— and of course smoking cessation.”
The Takeaway
- A lung CT scan is a simple procedure that can identify nodules in your lungs.
- A small, suspicious nodule might only require additional follow-up screening. A larger nodule of concern might require additional testing, such as a biopsy.
- False-positive results are possible, but the rates of false-positives from a lung CT scan have been declining.
- For those who receive a lung cancer diagnosis, modern treatments have improved survival rates for many patients, especially when detected early.
Resources We Trust
- Cleveland Clinic: Lung Cancer Screening
- Mayo Clinic: CT Scan
- American Lung Association: Lung Cancer Screening Resources
- Centers for Disease Control and Prevention: Screening for Lung Cancer
- Brown University Health: Preparing for Your CT Scan
- Lung Cancer Screening. Cleveland Clinic. August 16, 2024.
- CT Scan. Mayo Clinic. May 7, 2024.
- Slatore C et al. What Is a Lung Nodule? American Thoracic Society. June 2020.
- What Are Lung Nodules? LUNGevity. March 9, 2021.
- Sergev O. Fleischner Society Pulmonary Nodule Recommendations. Radiopaedia. February 6, 2025.
- Lung Biopsy. University of Rochester Medical Center.
- Robotic-Assisted Broncoscopy. American Lung Association. November 20, 2024.
- After Lung Cancer Screening, Follow-Up Procedures May Be Riskier Than Thought. National Cancer Institute. February 8, 2019.
- What to Expect From a Lung Cancer Screening. American Lung Association.
- Lagkadinou E. New Targeted Therapies Show Promise in Lung Cancer Treatment. Drug Target Review. December 13, 2024.

Michael S. Niederman, MD
Medical Reviewer
Michael S. Niederman, MD, is the lead academic and patient quality officer in the division of pulmonary and critical care medicine at Weill Cornell Medical Center in New York City; a professor of clinical medicine at Weill Cornell Medical College; and Lauder Family Professor in Pulmonary and Critical Care Medicine. He was previously the clinical director and associate chief in the division of pulmonary and critical care medicine at Weill Cornell Medical Center.
His focus is on respiratory infections, especially in critically ill patients, with a particular interest in disease pathogenisis, therapy, and ways to improve patient outcomes. His work related to respiratory tract infections includes mechanisms of airway colonization, the management of community- and hospital-acquired pneumonia, the role of guidelines for pneumonia, and the impact of antibiotic resistance on the management and outcomes of respiratory tract infections.
He obtained his medical degree from Boston University School of Medicine, then completed his training in internal medicine at Northwestern University School of Medicine, before undertaking a pulmonary and critical care fellowship at Yale University School of Medicine. Prior to joining Weill Cornell Medicine, he was a professor in the department of medicine at the State University of New York in Stony Brook and the chair of the department of medicine at Winthrop-University Hospital in Mineola, New York, for 16 years.
Dr. Niederman served as co-chair of the committees that created the American Thoracic Society's 1993 and 2001 guidelines for the treatment of community-acquired pneumonia and the 1996 and 2005 committees that wrote guidelines for the treatment of nosocomial pneumonia. He was a member of the American Thoracic Society/Infectious Diseases Society of America committee that published guidelines for community-acquired pneumonia in 2007. He was also the co-lead author of the 2017 guidelines on nosocomial pneumonia, written on behalf of the European Respiratory Society and the European Society of Intensive Care Medicine.
He has published over 400 peer-reviewed or review articles, and has lectured widely, both nationally and internationally. He was editor-in-chief of Clinical Pulmonary Medicine, is an associate editor of Critical Care and the European Respiratory Review, and serves on the editorial boards of Critical Care Medicine and Intensive Care Medicine. He has previously served on the editorial boards of the American Journal of Respiratory and Critical Care Medicine and Chest. For six years, he was a member of the Board of Regents of the American College of Chest Physicians, and in 2013, he was elected as a master of the American College of Physicians.

Julie Lynn Marks
Author
Julie Marks is a freelance writer with more than 20 years of experience covering health, lifestyle, and science topics. In addition to writing for Everyday Health, her work has been featured in WebMD, SELF, Healthline, A&E, Psych Central, Verywell Health, and more. Her goal is to compose helpful articles that readers can easily understand and use to improve their well-being. She is passionate about healthy living and delivering important medical information through her writing.
Prior to her freelance career, Marks was a supervising producer of medical programming for Ivanhoe Broadcast News. She is a Telly award winner and Freddie award finalist. When she’s not writing, she enjoys spending time with her husband and four children, traveling, and cheering on the UCF Knights.